Down's Syndrome Suppression of Tumour Growth and the Role of the Calcineurin Inhibitor DSCR1

Nature - United Kingdom
doi 10.1038/nature08062
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Preventability of Down's Syndrome

HSMHA Health Reports
1971English

The Role of Calcineurin/Nfat in SFRP2 Induced Angiogenesis—A Rationale for Breast Cancer Treatment With the Calcineurin Inhibitor Tacrolimus

PLoS ONE
Multidisciplinary
2011English

Spermicides and Down's Syndrome.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1982English

Estimating Risk of Down's Syndrome.

BMJ
1991English

Arginine Deiminase: A Potential Inhibitor of Angiogenesis and Tumour Growth

British Journal of Cancer
Cancer ResearchOncology
2003English

Calcineurin Inhibitor-Induced Endothelial Cell Injury – A Role for Complement

Molecular Immunology
ImmunologyMolecular Biology
2018English

Radiological Assessment of the Atlantoaxial Distance in Down's Syndrome.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1993English

Spermicide Use and Down's Syndrome.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1982English

Down's Syndrome, Longevity, and Alzheimer's Disease

British Journal of Psychiatry
MedicinePsychiatryMental Health
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy